Brain mapping is covered by insurance in some situations but not others, and the difference comes down to why it’s being done. If brain mapping is part of surgical planning for epilepsy or a brain tumor, most insurers will cover it. If it’s being used to evaluate ADHD, depression, anxiety, concussions, or to guide neurofeedback therapy, major insurers classify it as experimental and won’t pay for it. Out-of-pocket costs typically range from $300 to $1,000.
When Insurance Covers Brain Mapping
The clearest path to coverage is presurgical brain mapping. When a patient has drug-resistant epilepsy or a brain tumor and needs surgery, doctors use brain mapping to locate critical areas that control speech, movement, and vision so the surgeon can avoid them. Kaiser Permanente’s clinical criteria, for example, state that brain mapping with quantitative EEG “may be considered medically necessary when performed as part of presurgical planning to reduce morbidity after surgery to treat epilepsy or seizure disorders.”
Functional MRI used for presurgical planning also falls into this covered category. The FDA has cleared software specifically designed to process brain imaging data and generate maps of motor, language, and vision areas. When your neurologist or neurosurgeon orders these tests as part of a documented surgical plan, insurers generally treat them the same as other medically necessary imaging. Medicare covers MRI of the head when it is “reasonable and necessary for the diagnosis or treatment of the specific patient involved,” and brain mapping tied to a surgical procedure fits that standard.
Standard EEG monitoring for seizure diagnosis is also routinely covered. This includes 24-hour EEG monitoring to locate seizure activity, video EEG telemetry, and portable EEG recording. These are well-established diagnostic procedures with their own billing codes and aren’t controversial from an insurance standpoint.
When Insurance Denies Brain Mapping
The type of brain mapping most people search about is quantitative EEG, or qEEG. This is the version commonly marketed by neurofeedback clinics, integrative psychiatrists, and concussion centers. A qEEG records your brain’s electrical activity, then uses software to compare your patterns against a database to identify differences that may relate to a diagnosis or guide treatment. It’s the colorful brain map you’ve probably seen in ads for ADHD treatment or peak performance training.
Major insurers do not cover qEEG for these purposes. Aetna’s clinical policy bulletin explicitly labels quantitative EEG as “experimental, investigational, or unproven” for a long list of conditions: ADHD, depression, learning disabilities, OCD, panic disorder, PTSD, schizophrenia, sports concussions, and tinnitus. The policy notes that no leading medical professional organizations recommend qEEG as a screening test for neurological or psychiatric conditions.
This isn’t just Aetna. The “experimental and investigational” designation reflects a broader insurance industry consensus. When insurers use that label, it means they’ve reviewed the published research and concluded there isn’t enough evidence that the test changes patient outcomes in a meaningful way. Even if your clinician believes the qEEG provides useful information, that clinical opinion doesn’t override the insurer’s coverage policy.
Why the Distinction Exists
Insurance companies evaluate medical procedures based on whether there’s strong clinical evidence that the test leads to better treatment decisions. For presurgical brain mapping in epilepsy, the evidence is robust: identifying exactly where seizures originate and where critical brain functions are located directly reduces surgical complications. The test changes what the surgeon does and improves outcomes.
For qEEG in psychiatric and behavioral conditions, the evidence gap is different. The technology can detect patterns, but insurers and many medical organizations aren’t yet convinced that those patterns reliably translate into better diagnoses or treatment choices compared to standard clinical evaluation. A qEEG might show a pattern associated with ADHD, but the question insurers ask is whether that information leads to meaningfully different or better treatment than a thorough clinical assessment alone.
What You’ll Pay Out of Pocket
If your brain mapping falls into the “not covered” category, expect to pay between $300 and $1,000 for a qEEG session. Some clinics bundle the qEEG into a larger assessment package, while others charge it as a standalone fee. Clinics that offer neurofeedback therapy often require a qEEG as part of the initial evaluation, so this cost comes on top of the per-session neurofeedback fees that follow.
Prices vary based on your location, the clinic, and whether interpretation is included or billed separately. Before scheduling, ask for the total cost of the brain map plus the report and consultation where results are explained. Some clinics quote only the recording fee and add the analysis later.
How to Check Your Specific Coverage
If your doctor has recommended brain mapping, the first step is finding out the exact billing code they plan to use. The code determines how your insurer processes the claim. Code 95957, for example, covers digital EEG analysis and is used in some epilepsy evaluations. Functional cortical mapping during surgery has its own code. Ask the provider’s billing office which code applies to your situation.
Once you have the code, call the member services number on the back of your insurance card and ask whether that specific code is covered under your plan for your diagnosis. Get the representative’s name and a reference number for the call. If the procedure requires prior authorization, your doctor’s office will need to submit clinical documentation explaining why the test is medically necessary for your specific case. For presurgical mapping, this process is routine. For qEEG ordered by a psychiatrist or neurofeedback provider, expect the authorization to be denied.
If you’re denied and believe the test is genuinely medically necessary, you have the right to appeal. Your doctor can submit a letter of medical necessity along with supporting literature. Appeals for qEEG in psychiatric conditions rarely succeed with major commercial insurers given current policy positions, but the process exists and occasionally works with smaller or regional plans that haven’t issued explicit exclusion policies.
HSA and FSA Options
If your insurer won’t cover brain mapping, you can use funds from a health savings account (HSA) or flexible spending account (FSA) to pay for it. These accounts use pre-tax dollars, which effectively reduces your cost by your marginal tax rate. If you’re in a 22% tax bracket, a $500 brain map effectively costs you $390 when paid from an HSA. Check with your account administrator to confirm eligibility, as some plans have restrictions on what qualifies.